A 2012 BCC market research report showed that the global market for catheters was an estimated $21.2 billion in 2011. The global market for the medical device is expected to increase to more than $32 billion in 2016. Helping to meet the growing demand for this device, TriReme Medical developed a catheter with a larger matrix size, which was recently cleared by the Food and Drug Administration.The TriReme Chocolate balloon catheter is now approved for use in treatment of lesions in diameters from two to four millimeters and in balloon lengths up to 120 millimeters. A catheter is a hollow tube that can be inserted into blood vessel, duct or body cavity to drain and infuse fluids.
"This latest regulatory approval broadening the available size matrix of the Chocolate PTA Balloon marks yet another important milestone for TriReme Medical," said Eitan Konstantino, president and CEO. "There is more to come; our goal is to provide a broad range of innovative tools to improve outcomes in patients suffering from complex vascular disease."
TriReme is a private company based in California and Singapore.
Post A Comment:
0 comments so far,add yours